losartan has been researched along with triazoles in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaine, EH; Blehm, DJ; Corpus, VM; Huang, HC; Manning, RE; McMahon, EG; Olins, GM; Palomo, MA; Reitz, DB; Schuh, JR | 1 |
| Ashton, WT; Chang, LL; Flanagan, K; Gabel, RA; Greenlee, WJ; Kivlighn, SD; Schaffer, LW; Schorn, TW; Siegl, PK; Zingaro, GJ | 1 |
| Blaine, EH; Huang, HC; Koepke, JP; Manning, RE; Olins, GM; Reitz, DB; Smits, GJ | 1 |
| Fujimori, A; Inagaki, O; Kikuchi, K; Kurihara, H; Okazaki, T; Shibasaki, M; Suga, A; Watanabe, T; Yanagisawa, U | 1 |
| Wang, Q; Wang, W; Wang, Y; Wu, J; Wu, X; Xu, J | 1 |
| Guo, J; Hu, Z; Wang, Q; Wu, J; Wu, X; Xu, J; Yin, Z | 1 |
| Aihara, Y; Fukui, H; Ikenaka, Y; Kaji, K; Kawaratani, H; Kitade, M; Namisaki, T; Noguchi, R; Shirai, Y; Tsujimoto, T; Yanase, K; Yoshii, J; Yoshiji, H | 1 |
| Lam, SY; Leung, KK; Leung, PS; Liang, J | 1 |
| Arafat, T; Idkaidek, N | 1 |
9 other study(ies) available for losartan and triazoles
| Article | Year |
|---|---|
In vitro pharmacology of a nonpeptidic angiotensin II receptor antagonist, SC-51316.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cell Membrane; Female; Imidazoles; Kidney; Losartan; Muscle, Smooth, Vascular; Rats; Receptors, Angiotensin; Renin; Tetrazoles; Triazoles; Uterus | 1992 |
In vivo pharmacology of L-159,913, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Dogs; Female; Hypertension; Imidazoles; Kidney; Losartan; Macaca mulatta; Male; Natriuresis; Pan troglodytes; Potassium; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin; Tetrazoles; Triazoles | 1995 |
In vivo pharmacology of SC-51316, a nonpeptidic angiotensin II receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Depression, Chemical; Dogs; Dose-Response Relationship, Drug; Enalapril; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Tetrazoles; Triazoles | 1993 |
Studies on nonpeptide angiotensin II receptor antagonists. I. Synthesis and biological evaluation of pyrazolo[1,5-b][1,2,4]triazole derivatives with alkyl substituents.
Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Azoles; Biphenyl Compounds; Blood Pressure; Diuretics; Dogs; Dose-Response Relationship, Drug; Female; Furosemide; Losartan; Male; Muscle, Smooth, Vascular; Pyrazoles; Rabbits; Rats; Rats, Wistar; Structure-Activity Relationship; Triazoles | 1998 |
[Ca2+]i and PKC-alpha are involved in the inhibitory effects of Ib, a novel nonpeptide AngiotensinII subtype AT1 receptor antagonist, on AngiotensinII-induced vascular contraction in vitro.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Calcium; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Protein Kinase C-alpha; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Triazoles | 2007 |
Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Cattle; Cerebellum; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Injections, Intravenous; Liver; Losartan; Male; Protein Binding; Pyrroles; Rabbits; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Time Factors; Triazoles; Vasoconstriction | 2008 |
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
Topics: Administration, Oral; Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzoates; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Choline Deficiency; Deferasirox; Disease Progression; Drug Therapy, Combination; Fatty Liver; Hepatic Stellate Cells; Iron Chelating Agents; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Losartan; Male; Neovascularization, Pathologic; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Inbred F344; Time Factors; Transforming Growth Factor beta1; Triazoles | 2011 |
Combined treatment with a dipeptidyl peptidase-IV inhibitor (sitagliptin) and an angiotensin II type 1 receptor blocker (losartan) promotes islet regeneration via enhanced differentiation of pancreatic progenitor cells.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Humans; Islets of Langerhans; Losartan; Male; Mice; Pyrazines; Regeneration; Sitagliptin Phosphate; Stem Cells; Triazoles | 2012 |
Saliva versus plasma pharmacokinetics: theory and application of a salivary excretion classification system.
Topics: Acetates; Anthraquinones; Azithromycin; Benzhydryl Compounds; Cinacalcet; Cloxacillin; Cresols; Cyclopropanes; Female; Fluorobenzenes; Humans; Hydrochlorothiazide; Losartan; Male; Metformin; Naphthalenes; Phenylpropanolamine; Piroxicam; Pyrazines; Pyrimidines; Quinolines; Rosuvastatin Calcium; Saliva; Sitagliptin Phosphate; Sulfides; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Triazoles | 2012 |